loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 210632 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 FRESENIUS KABI USA (3)

filter

01 SOLUTION;INTRAVENOUS (3)

filter

01 RX (3)

filter

01 LEVOTHYROXINE SODIUM (3)

filter

01 Yes (3)

URL Supplier Web Content
SOLUTION; INTRAVEN...
500MCG/5ML (100MCG...
2019-04-11
210632
LEVOTHYROXINE SODI...
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION; INTRAVEN...
100MCG/5ML (20MCG/...
2019-04-11
210632
LEVOTHYROXINE SODI...
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION; INTRAVEN...
200MCG/5ML (40MCG/...
2019-04-11
210632
LEVOTHYROXINE SODI...
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 210632

Looking for FDA Orange Book APPLICATION 210632 3

19

Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 210632.

Regulatory Information RX

With a dosage strength 500MCG/5ML (100MCG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2019-04-11

18

Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 210632.

Regulatory Information RX

With a dosage strength 100MCG/5ML (20MCG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2019-04-11

17

Fresenius Kabi USA, LLC, based in Austria, is a pharmaceutical company.

One of their notable products is LEVOTHYROXINE SODIUM, with a corresponding application number 210632.

Regulatory Information RX

With a dosage strength 200MCG/5ML (40MCG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug Yes

Approved since 2019-04-11

Post Enquiry
POST ENQUIRY